Morel C, Benard Y, Vergnaud M, Langeard M
Nouv Presse Med. 1982 Feb 4;11(5 Pt 2):365-7.
The penetration of mezlocillin into bronchial secretions collected by fiberoscopy was determined in 18 hospital patients with acute-on-chronic bronchial infection. Samples of blood and bronchial mucus were collected simultaneously 3 hours after each 12-hourly intramuscular injection of 1 g mezlocillin. Antibiotic concentrations were measured by the microbiological method. Mezlocillin concentrations in bronchial secretions averaged 50 % of concomitant serum concentrations. The rate of penetration of the drug was higher than that observed with ampicillin in similar conditions. The mean bronchial level of 3 micrograms/ml was indicative of a high therapeutic index in relation to the MICs of the pathogens isolated in these patients. It is concluded that intramuscular mezlocillin is indicated for the treatment of acute exacerbations of chronic bronchial infections due to highly sensitive organisms.
在18例患有慢性支气管炎急性感染的住院患者中,测定了美洛西林在经纤维镜检查采集的支气管分泌物中的渗透情况。在每12小时肌肉注射1g美洛西林后的3小时,同时采集血液和支气管黏液样本。采用微生物学方法测定抗生素浓度。支气管分泌物中美洛西林浓度平均为同期血清浓度的50%。在类似条件下,该药物的渗透速率高于氨苄西林。3微克/毫升的平均支气管药物水平表明,相对于这些患者中分离出的病原体的最低抑菌浓度(MIC)而言,其治疗指数较高。结论是,肌肉注射美洛西林适用于治疗由高度敏感菌引起的慢性支气管感染急性加重。